Convient-il de breveter les gènes ? Une analyse économique

Claude Henry

Working Papers from HAL

Abstract: The costs, in terms of inhibiting further research and innovation, of patenting genes, are larger than the benefits, in terms of added incentives to the effort of identifying genes ; it is thus economically detrimental to patent genes. For those which are already patented, compulsory licensing should be viewed as analogous to regulating the access to essential facilities in network utilities.

Keywords: Patent; Competition; Compulsory licensing; Brevet; Concurrence; License obligatoire; Régulation (search for similar items in EconPapers)
Date: 2003
Note: View the original document on HAL open archive server: https://hal.science/hal-00242946
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://hal.science/hal-00242946/document (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:wpaper:hal-00242946

Access Statistics for this paper

More papers in Working Papers from HAL
Bibliographic data for series maintained by CCSD ().